Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 1631 entries
View as:

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Phase: N/A Priority: Normal
NCT ID: NCT01043523 Org: User:
Start: 12/31/09 End: 04/30/13 Due: 04/30/14

Second Primary Cancers in Patients With Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02702908 Org: User:
Start: 03/15/16 End: 10/20/17 Due: 10/20/18

Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01005719 Org: User:
Start: 09/30/09 End: 01/31/10 Due: 01/31/11

Dose Finding Study of Gadavist in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Phase: N/A Priority: Normal
NCT ID: NCT00862459 Org: User:
Start: 08/31/05 End: 03/31/07 Due: 03/31/08

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Phase: N/A Priority: Normal
NCT ID: NCT04364464 Org: User:
Start: 02/19/10 End: 09/20/11 Due: 09/20/12

18751-Sun Protection Factor Assay.

Phase: N/A Priority: Normal
NCT ID: NCT02739802 Org: User:
Start: 03/15/16 End: 03/30/16 Due: 03/30/17

Physical Disability in Patients Treated With Betaferon

Phase: N/A Priority: Normal
NCT ID: NCT00873340 Org: User:
Start: 10/31/07 End: 01/31/11 Due: 01/31/12

Effect of Aprotinin on Transfusion Requirements and Blood Loss in Patients Undergoing Elective Primary Total Hip Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00668031 Org: User:
Start: 02/28/05 End: 01/31/06 Due: 01/31/07

18750-Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02741466 Org: User:
Start: 03/15/16 End: 03/30/16 Due: 03/30/17

Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients

Phase: N/A Priority: Normal
NCT ID: NCT01781052 Org: User:
Start: 09/11/13 End: 01/16/17 Due: 01/16/18

Bioequivalence Study of BAY 77-1931 Orally Disintegrating Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03074058 Org: User:
Start: 06/10/15 End: 08/21/15 Due: 08/21/16

Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US

Phase: N/A Priority: Normal
NCT ID: NCT02788409 Org: User:
Start: 05/15/16 End: 05/09/18 Due: 05/09/19

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04509193 Org: User:
Start: 08/21/20 End: 07/31/21 Due: 07/31/22

Oral Rivaroxaban in Children With Venous Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT01684423 Org: User:
Start: 02/19/13 End: 09/01/16 Due: 09/01/17

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

Phase: N/A Priority: Normal
NCT ID: NCT02367040 Org: User:
Start: 08/03/15 End: 11/15/24 Due: 11/15/25

Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration

Phase: N/A Priority: Normal
NCT ID: NCT01184820 Org: User:
Start: 10/13/10 End: 10/10/11 Due: 10/10/12

EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis

Phase: N/A Priority: Normal
NCT ID: NCT02309411 Org: User:
Start: 01/15/15 End: 04/05/17 Due: 04/05/18

Interaction With HIV Antiretroviral Agents

Phase: N/A Priority: Normal
NCT ID: NCT02556268 Org: User:
Start: 02/23/16 End: 12/07/16 Due: 12/07/17

Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980

Phase: N/A Priority: Normal
NCT ID: NCT00629837 Org: User:
Start: 09/30/05 End: 03/31/06 Due: 03/31/07

A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea

Phase: N/A Priority: Normal
NCT ID: NCT04713826 Org: User:
Start: 03/03/21 End: 11/11/21 Due: 11/11/22

LCS16 vs. COC User Satisfaction and Tolerability Study

Phase: N/A Priority: Normal
NCT ID: NCT03074045 Org: User:
Start: 03/13/17 End: 08/05/22 Due: 08/05/23

Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02696642 Org: User:
Start: 04/14/16 End: 08/19/19 Due: 08/19/20

Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01411436 Org: User:
Start: 05/31/09 End: 02/28/15 Due: 02/28/16

Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00663845 Org: User:
Start: 05/31/06 End: 04/30/07 Due: 04/30/08

A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT00810693 Org: User:
Start: 12/17/08 End: 05/14/12 Due: 05/14/13